2020
DOI: 10.1038/s41433-020-1056-0
|View full text |Cite
|
Sign up to set email alerts
|

Delayed presentation and increased prevalence of proliferative vitreoretinopathy for primary rhegmatogenous retinal detachments presenting during the COVID-19 pandemic lockdown

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

4
41
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(48 citation statements)
references
References 5 publications
4
41
3
Order By: Relevance
“…Contrary to other reports from the United Kingdom and North America 11 , 12 , 13 , 14 , 16 citing a significant reduction in the total volume of RDs seen over a 3- to 5-month period from the onset of the pandemic, we continued to treat a high volume of patients for the 6 months after March 14, 2020 ( Fig. 1 ).…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…Contrary to other reports from the United Kingdom and North America 11 , 12 , 13 , 14 , 16 citing a significant reduction in the total volume of RDs seen over a 3- to 5-month period from the onset of the pandemic, we continued to treat a high volume of patients for the 6 months after March 14, 2020 ( Fig. 1 ).…”
Section: Discussionmentioning
confidence: 72%
“… 9 , 10 Small studies from the United Kingdom and North America have reported lower numbers of RD presentations within 1 to 3 months of the COVID-19 pandemic. 11 , 12 , 13 , 14 Although not statistically significant, previous authors have reported a reduced percentage of macula-on detachments, and a higher incidence of proliferative vitreoretinopathy (PVR) after the onset of the pandemic.…”
mentioning
confidence: 83%
“…The effects of COVID-19 on the presentation of VR pathologies have discussed in recent publications. 3,4 Poyser et al 4 showed a higher proportion of RRD presenting with macula off status and Awad et al 3 reported a significant increase in proliferative vitreoretinopathy RRD following COVID-19. To the best of our knowledge, this is the first study to investigate the effect of COVID-19 compared to pre-COVID-19 period on the clinical presentation of the retinal tears and overall outcome of retinopexies Despite the proportion of treatment episodes of retinopexy each patient had remained the same between both groups, our study showed a significant increase in RRD rate following primary retinopexy in Group 2.…”
Section: Discussionmentioning
confidence: 99%
“…The impact of COVID-19 on primary retinopexy in preventing retinal detachment in a tertiary eye hospital emergency department COVID-19 period. 3,4 An example is a report by Wickham et al 5 that has shown a marked decrease in presentation of retinal detachments to Moorfields Eye Hospital.…”
Section: Introductionmentioning
confidence: 99%
“…The COVID-19 pandemic poses specific challenges to ophthalmology service delivery with social distancing, frequent changes in restrictions, isolation and quarantine periods and patient anxieties around contracting coronavirus affecting both acute and routine patient care. The effects of delayed acute presentations have already been widely reported with the impact on chronic conditions beginning to emerge [ 12 , 13 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%